Logo
x

Search

Subscribe Now

Solid Tumor

Impact Receives US FDA's IND Clearance for IMP9064 to Treat Solid Tumor

Impact Receives US FDA's IND Clearance for IMP9064 to Treat Solid Tumor

  • October 29, 2021
Exclusive Interview with PharmaShots: Jonathan Benjamin of Atreca Share Insight on the Data of ATRC-101 to Treat Solid Tumor

Exclusive Interview with PharmaShots: Jonathan Benjamin of Atreca Share Insight on the Data of ATRC-101 to Treat Solid Tumor

  • October 22, 2021
Merck Signs an Exclusive Worldwide License Agreement with Artiva to Develop CAR-NK Cell Therapies

Merck Signs an Exclusive Worldwide License Agreement with Artiva to Develop CAR-NK Cell Therapies

  • January 29, 2021
BMS Signs an Exclusive Worldwide License Agreement with Dragonfly Therapeutics for DF6002

BMS Signs an Exclusive Worldwide License Agreement with Dragonfly Therapeutics for DF6002

  • August 17, 2020
BioInvent Reports the Enrollment of First Patient in P-I/IIa Study of BI-1206 + Keytruda for Solid Tumors

BioInvent Reports the Enrollment of First Patient in P-I/IIa Study of BI-1206 + Keytruda for Solid Tumors

  • June 23, 2020
Tilt Biotherapeutics Signs an Agreement with Merck KGaA and Pfizer to Investigate the Dual Combination for Solid Tumors

Tilt Biotherapeutics Signs an Agreement with Merck KGaA and Pfizer to Investigate the Dual Combination for Solid Tumors

  • June 26, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.